These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36250542)

  • 1. Characterization of Intercalated Cell Markers KIT and
    Mannan R; Wang X; Bawa PS; Zhang Y; Skala SL; Chinnaiyan AK; Dagar A; Wang L; Zelenka-Wang SB; McMurry LM; Daniel N; Cao X; Sangoi AR; Gupta S; Vaishampayan UN; Hafez KS; Morgan TM; Spratt DE; Tretiakova MS; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Int J Surg Pathol; 2023 Sep; 31(6):1027-1040. PubMed ID: 36250542
    [No Abstract]   [Full Text] [Related]  

  • 2. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
    Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.
    Kuroda N; Tanaka A; Yamaguchi T; Kasahara K; Naruse K; Yamada Y; Hatanaka K; Shinohara N; Nagashima Y; Mikami S; Oya M; Hamashima T; Michal M; Hes O
    Med Mol Morphol; 2013 Mar; 46(1):49-55. PubMed ID: 23338778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
    Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
    Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromophobe renal cell carcinoma: current and controversial issues.
    Moch H; Ohashi R
    Pathology; 2021 Jan; 53(1):101-108. PubMed ID: 33183792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
    Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal cell tumors with an entrapped papillary component: a collision with predilection for oncocytic tumors.
    Williamson SR; Cheng L; Gadde R; Giannico GA; Wasco MJ; Taylor Smith PJ; Gupta NS; Grignon DJ; Jorda M; Kryvenko ON
    Virchows Arch; 2020 Mar; 476(3):399-407. PubMed ID: 31444626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.
    Wang XM; Mannan R; Zhang Y; Chinnaiyan A; Rangaswamy R; Chugh S; Su F; Cao X; Wang R; Skala SL; Hafez KS; Vaishampayan U; Mckenney J; Picken MM; Gupta S; Alaghehbandan R; Tretiakova M; Argani P; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2024 Feb; 48(2):163-173. PubMed ID: 37994665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic approach to eosinophilic renal neoplasms.
    Kryvenko ON; Jorda M; Argani P; Epstein JI
    Arch Pathol Lab Med; 2014 Nov; 138(11):1531-41. PubMed ID: 25357116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors.
    Tickoo SK; Amin MB; Linden MD; Lee MW; Zarbo RJ
    Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostaining characteristics of irisin in benign and malignant renal cancers.
    Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
    Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncocytic renal neoplasms: diagnostic considerations.
    Abrahams NA; Tamboli P
    Clin Lab Med; 2005 Jun; 25(2):317-39, vi. PubMed ID: 15848739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.
    Shen SS; Krishna B; Chirala R; Amato RJ; Truong LD
    Mod Pathol; 2005 Jul; 18(7):933-40. PubMed ID: 15696118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.